Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation

78589

GIPR/CRE Luciferase Reporter HEK293 Cell Line

BPS Bioscience

DESCRIPTION

Recombinant HEK293 cells expressing the firefly luciferase gene under the control of cAMP response element (CRE), and with forced expression of human GIPR (Gastric Inhibitory Polypeptide receptor; NM_000164.4). Activation of GIPR in these cells can be monitored by measuring luciferase activity. The functionality of the GIPR/CRE Luciferase Reporter HEK293 Cell Line was validated in a dose-response assay using agonists gastric inhibitory peptide (GIP) and tirzepatide hydrochloride. These agonists induce luciferase activity in a dose-dependent manner as depicted in Figure 1. Figure 1. Illustration of the GIPR/CRE Luciferase Reporter HEK293 Cell line.

DETAILS

  • Notes: License Disclosure: Visit bpsbioscience.com/license for the label license and other key information about this product.  Troubleshooting Guide: Visit bpsbioscience.com/cell-line-faq for detailed troubleshooting instructions. For all further questions, please email support@bpsbioscience.com.
  • Uniprot: P48546
  • Shiptemp: -80°C (dry ice)
  • Synonyms: Gastric inhibitory polypeptide receptor, GIP-R, Glucose-dependent insulinotropic polypeptide receptor, GIPR
  • Warnings: Avoid freeze/thaw cycles
  • Category: Cell Signaling/Cell Line
  • Background: The gastric inhibitory polypeptide receptor (GIPR), also known as the glucose-dependent insulinotropic polypeptide receptor belongs to the Class B1 G protein-coupled receptor (GPCR) family. GIPR is primarily found in the β-cells of the pancreas and serves as a receptor for the gastric inhibitory polypeptide (GIP) hormone. As one of the incretin hormones, GIP modulates glucose metabolism by stimulating the pancreatic β-cells to release insulin. Since GIPR/GLP-1R heterodimerization has been shown to regulate GLP-1R signaling, dual agonists that bind both GIPR and GLP-1R have shown promising clinical efficacy for treating type II diabetes mellitus (T2DM) and obesity.  
  • Description: Recombinant HEK293 cells expressing the firefly luciferase gene under the control of cAMP response element (CRE), and with forced expression of human GIPR (Gastric Inhibitory Polypeptide receptor; NM_000164.4). Activation of GIPR in these cells can be monitored by measuring luciferase activity. The functionality of the GIPR/CRE Luciferase Reporter HEK293 Cell Line was validated in a dose-response assay using agonists gastric inhibitory peptide (GIP) and tirzepatide hydrochloride. These agonists induce luciferase activity in a dose-dependent manner as depicted in Figure 1. Figure 1. Illustration of the GIPR/CRE Luciferase Reporter HEK293 Cell line.
  • Supplied As: Each vial contains ~2 x 106 cells in 1 ml of cell freezing medium (BPS Bioscience, #79796)
  • Unspsc Code: 41106514
  • Unspsc Name: Stable mammalian cell lines
  • Applications: Screen and characterize agonists of human GIPR in a cellular context
  • Host Species: human
  • Product Type: Cell Line
  • Host Cell Line: HEK293, Human Embryonic Kidney, epithelial-like cells, adherent
  • Biosafety Level: BSL-2
  • Related Products: 60690, 79544, 60187, 78176
  • Storage Stability: Cells are shipped in dry ice and should immediately be thawed or stored in liquid nitrogen upon receipt. Do not use a -80°C freezer for long term storage. 
  • Mycoplasma Testing: The cell line has been screened to confirm the absence of Mycoplasma species.
  • Scientific Category: Cell Signaling Pathway
  • Required Accessories: 60187,79544,79796,60690
  • Signed License Required: Yes